Leadership Team

The Leadership Team at WaveBreak is responsible for setting the strategic direction and vision of the company, ensuring alignment and progress towards transforming drug discovery for neurodegenerative diseases. They steer major initiatives, drive innovation, manage high-level research and development, and foster partnerships to advance the company's drug discovery platform. With a focus on targeting transient protein intermediates, the team aims to develop breakthrough small-molecule therapeutics for conditions like Parkinson’s disease, Lewy body dementia, Alzheimer’s disease, and ALS.